Child pollen anti-allergic drug raw material formula

A technology of anti-allergic drugs and raw materials, which is applied in the direction of pharmaceutical formulations, plant raw materials, allergic diseases, etc., can solve the problems of easy pollen allergy, non-eradication, and large side effects, so as to achieve good prevention and treatment, less harm to children, and side effects small effect

Inactive Publication Date: 2019-01-25
HUBEI CHENGYU PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This new type of medication can help fight against certain types of food that cause anaphylaxis or other health issues during pregnancy by reducing their symptoms quickly without causing any negative reactions like itching sensations for some people who have been exposed to this chemical substance over time.

Problems solved by technology

The technical problem addressed in this patented text relates to treating polyp allergy that occurs during childhood due to an inherited sensitization made up primarily from certain types of foods called egg white protein (ESP). Traditional methods involve taking medication over several months before it'll work effectively against symptoms like asthma attacks without causing any harmful side-effects such as heartburn or other negative health consequences associated with these conditions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] A children's pollen antiallergic drug raw material formula, which has the following raw material drug composition in the following weight ratio: 8 parts of ginseng, 10 parts of Schizonepeta, 14 parts of honeysuckle, 8 parts of tangerine peel, 15 parts of coix seed, 13 parts of baiji, 17 parts of Astragalus, 5 parts of Evodia, 8 parts of Pinellia, 7 parts of Rhodiola, 10 parts of Pingcheqian, and 4 parts of perilla.

Embodiment 2

[0013] A children's pollen antiallergic drug raw material formula, which comprises the following raw material drug composition in weight ratio: 11 parts of ginseng, 16 parts of nepeta, 14 parts of honeysuckle, 11 parts of tangerine peel, 23 parts of coix seed, 20 parts of baiji, 18 parts of Astragalus, 6 parts of Evodia, 10 parts of Pinellia, 12 parts of Rhodiola, 14 parts of Plantago, and 8 parts of perilla.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a child pollen anti-allergic drug raw material formula, which comprises a raw material medicine composition comprising the following weight ratios: 7-12 part of ginseng, 9-18 parts of schizonepeta, 12-15 part of honeysuckle, 6-12 parts of dried orange peel, 13-24 parts of coix see, 12-23 parts of rhizoma bletilla, 14-22 parts of astragalus root, 3-7 parts of evodia rutaecarpa, 7-12 parts of rhizoma pinelliae Preparata, 6-13 parts of rhodiola root, 7-16 parts of placenta and 3-7 parts of perilla fructus. The Chinese-medicinal materials have good effect on preventing andtreating allergic diseases, short course of treatment, quick effect, little side effect, little harm to children, and good taste.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner HUBEI CHENGYU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products